Uncategorized
Johnson & Johnson Vision focused on lifetime of eye care
During the European Society of Cataract and Refractive Surgeons meeting in Lisbon, Portugal, Ocular Surgery News spoke with Thomas G. Frinzi, worldwide president, surgical, at Johnson & Johnson Vision, about the recent acquisitions and future prospects of the company.
OSN: How does the TearScience acquisition play into the Johnson & Johnson Vision pipeline?
Frinzi: We are all excited about adding TearScience to the portfolio. With roughly 340 million people suffering from dry eye around the world, dry eye is a growing market opportunity, increasing at a rate of (Read more...)